Category:Antipsychotics

• Antipsychotic

*

• Antipsychotic switching
• Extrapyramidal symptoms
• Neuroleptic malignant syndrome
• NMDA receptor modulator

0–9

• 3-PPP

A

• Alentemol
• Alstonine
• Template:Antipsychotics
• Antipsychotics abuse
• Ataractive
• AVN-211
• Azacyclonol

B

• Batelapine
• Benzquinamide
• Biphenylindanone A
• BL-1020
• Bradanicline
• Butaclamol

C

• CBiPES
• Ciclindole
• Clorotepine
• Cyproheptadine

D

• Desmethylclozapine

E

• Enciprazine
• Erteberel
• Estradiol butyrylacetate/testosterone ketolaurate/reserpine
• Evenamide

F

• F-15063
• Fananserin
• Flucindole
• 4'-Fluorocannabidiol
• Fluotracen
• Flupentixol/melitracen
• Fluperlapine

G

• GTS-21

H

• Hematoporphyrin
• Homopipramol

L

• Levosulpiride
• List of antipsychotics
• List of investigational antipsychotics
• List of long term side effects of antipsychotics
• Liverpool University Neuroleptic Side-Effect Rating Scale

M

• Mazapertine
• Mesdopetam
• Metergoline
• Metitepine
• Molindone

N

• NBI-1117568
• Neboglamine
• Neuroleptanalgesic
• Neuroleptic-induced deficit syndrome

O

• Ocaperidone
• Osanetant
• Oxiperomide
• Oxypertine

P

• Panamesine
• Perathiepin
• Template:Pharmacokinetics of long-acting injectable antipsychotics
• Pinoxepin
• Pirenperone
• Pleurothotonus

R

• Ralmitaront
• Roluperidone

S

• SEP-4199

T

• Talnetant
• Tilapertin
• Tiospirone
• Tranylcypromine/trifluoperazine
• Triflupromazine
• Trimipramine

U

• Ulotaront

V

• Vabicaserin

X

• Xanomeline